GB1546479A - Cefazolin suspension for parenteral administration - Google Patents

Cefazolin suspension for parenteral administration

Info

Publication number
GB1546479A
GB1546479A GB16489/76A GB1648976A GB1546479A GB 1546479 A GB1546479 A GB 1546479A GB 16489/76 A GB16489/76 A GB 16489/76A GB 1648976 A GB1648976 A GB 1648976A GB 1546479 A GB1546479 A GB 1546479A
Authority
GB
United Kingdom
Prior art keywords
cefazolin
suspension
parenteral administration
parenteral
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB16489/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of GB1546479A publication Critical patent/GB1546479A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB16489/76A 1975-04-28 1976-04-23 Cefazolin suspension for parenteral administration Expired GB1546479A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/573,283 US4029782A (en) 1975-04-28 1975-04-28 Cefazolin suspension for parenteral administration

Publications (1)

Publication Number Publication Date
GB1546479A true GB1546479A (en) 1979-05-23

Family

ID=24291351

Family Applications (1)

Application Number Title Priority Date Filing Date
GB16489/76A Expired GB1546479A (en) 1975-04-28 1976-04-23 Cefazolin suspension for parenteral administration

Country Status (8)

Country Link
US (1) US4029782A (https=)
JP (1) JPS51130522A (https=)
AU (1) AU505940B2 (https=)
BE (1) BE841157A (https=)
DE (1) DE2618422A1 (https=)
FR (1) FR2309211A1 (https=)
GB (1) GB1546479A (https=)
ZA (1) ZA761476B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
GB8322364D0 (en) * 1983-08-19 1983-09-21 May & Baker Ltd Compositions of matter
US6660049B1 (en) 1996-07-31 2003-12-09 Natural Soda Aala, Inc. Process for control of crystallization of inorganics from aqueous solutions
US6495164B1 (en) * 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
RU2310450C2 (ru) * 2002-10-25 2007-11-20 Пфайзер Продактс Инк. Новые депо-препараты для инъекций

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297692A (en) * 1961-04-03 1967-01-10 Lilly Co Eli 7-alkylmercaptoacetamidocephalosporanic acid
GB1051746A (https=) * 1961-12-22
US3293133A (en) * 1963-04-24 1966-12-20 Squibb & Sons Inc Method of imparting color to pharmaceutical solutions
CH557381A (de) * 1967-04-15 1974-12-31 Fujisawa Pharmaceutical Co Verfahren zur herstellung von (delta)3-cephemverbindungen.
GB1244501A (en) * 1968-03-09 1971-09-02 Aspro Nicholas Ltd Heterocyclic amines
US3678163A (en) * 1969-06-02 1972-07-18 Merck & Co Inc Stabilized aqueous suspension of calcium (-) (cis-1,2-epoxypropyl)-phosphonate
US3897423A (en) * 1973-03-05 1975-07-29 Squibb & Sons Inc Amino substituted acylthio cephalosporins

Also Published As

Publication number Publication date
ZA761476B (en) 1977-10-26
BE841157A (fr) 1976-10-27
AU1186876A (en) 1977-09-15
DE2618422A1 (de) 1976-11-11
FR2309211B1 (https=) 1979-03-23
JPS51130522A (en) 1976-11-12
US4029782A (en) 1977-06-14
FR2309211A1 (fr) 1976-11-26
AU505940B2 (en) 1979-12-06

Similar Documents

Publication Publication Date Title
PT65863A (en) Capsules
JPS5214503A (en) Phosphorusscontaining tantalum
JPS5254278A (en) Solid stabilizer
GB1546958A (en) Bottom bracket assemblies for bicvcles
CS191969B2 (en) Vertical centrifuge
GB1539261A (en) Cover-sealing arrangement
AU2015876A (en) Parenteral administration set
JPS5210300A (en) *nichinichika* alkaroid derivative
HK35282A (en) Rifamycin derivatives
ZA765877B (en) Synchronising arrangement
JPS51147306A (en) Stabilizer
JPS51129028A (en) Suspension system
GB1486118A (en) Rifamycin derivatives
JPS5251619A (en) Suspension assembly
ZA761476B (en) Cefazolin suspension for parenteral administration
GB1543043A (en) Racking mechanisms
GB1546943A (en) Suspension system
CH607921A5 (en) Infusion/flushing arrangement
GB1517385A (en) Phenothiazine derivatives
PH13321A (en) Cephalosporin derivative
JPS5180613A (en) Kyodo jinseinosuguretatanzohinnoseizohoho
JPS5267878A (en) Vertical type filterrhydroextractor
JPS529537A (en) Hanger
JPS5276309A (en) Tublar refractories
JPS51112676A (en) Hanger

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee